{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3908, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "business_model", "function": "summarize", "notes": "Uses a 2x2 grid layout to present four key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/27", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "cfef2b8d-039e-4e41-bca4-dae0970a35b9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financial Overview", "beatSlug": "sequoia-pitch-financials", "evidence": "The deck presents a financial overview, growth model, and capital structure.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/28", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 21, "beatId": "cfef2b8d-039e-4e41-bca4-dae0970a35b9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financial Overview", "beatSlug": "sequoia-pitch-financials", "evidence": "The deck presents a financial overview, growth model, and capital structure.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "closing_ask", "function": "summarize", "notes": "This is a closing slide for an investor presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/29", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-29", "loopMatches": [ { "to": 30, "from": 29, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "ae3f8f55-5074-4794-ba2a-5ee9de225741", "evidence": "The deck concludes with a clear call to action and vision for making global trade frictionless.", "position": 1, "objective": "Emphasize the vision", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/30", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-30", "loopMatches": [ { "to": 30, "from": 29, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "ae3f8f55-5074-4794-ba2a-5ee9de225741", "evidence": "The deck concludes with a clear call to action and vision for making global trade frictionless.", "position": 1, "objective": "Emphasize the vision", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/31", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes a footnote regarding non-recurring share listing expenses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/32", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table shows adjustments for share-based compensation and depreciation & amortization to arrive at non-IFRS metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/33", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table provides a clear breakdown of non-cash and non-recurring items used to adjust the operating loss.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/34", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table shows a significant increase in operating loss in 2023, largely driven by share-listing expenses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/35", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/36", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table details non-cash and non-recurring items to arrive at Adjusted EBITDA.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/37", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/38", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-57df-7605-b08c-67ed30a73d92", "docSlug": "4d12e8d88d2e09e46252b10009547df1", "documentTitle": "Freightos | Investor Presentation Deck | 39 slides", "authorId": "freightos", "authorName": "Freightos", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "business_model", "function": "present_framework", "notes": "The slide uses a structured table to explain how network effects are being scaled.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-57df-7605-b08c-67ed30a73d92/39", "deckHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92", "deckAnchorHref": "/decks/019de077-57df-7605-b08c-67ed30a73d92#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/nTbrWZIgp3I_llF9Xlmgdg-8Xv944fkgBaJVLWgJSWk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNWE2ZTUzZTE1ZjE3MmVjM2E3ZTRiMWY0NzNlYWE0Mi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/1", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "b1cbc440-01c4-465c-baef-839a0079e508", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction to Genprex and its mission", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/wy1wI6ViJpLgYtGCsAhWcFnoZYovfpbu2XSk2Q7aNJw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNWE2ZTUzZTE1ZjE3MmVjM2E3ZTRiMWY0NzNlYWE0Mi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/NBENNV6qozPTPvN_xUg8QSLm3Xzpp-dJ3PwFpyqW5Yo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNWE2ZTUzZTE1ZjE3MmVjM2E3ZTRiMWY0NzNlYWE0Mi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/QI_9GRk4tdA1kxhLpm8LJgIF_fRzuLZEP5LZ3ENh-XM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNWE2ZTUzZTE1ZjE3MmVjM2E3ZTRiMWY0NzNlYWE0Mi9wMDAxLnBuZw" }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/2", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "b1cbc440-01c4-465c-baef-839a0079e508", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction to Genprex and its mission", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "mission", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/3", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "b1cbc440-01c4-465c-baef-839a0079e508", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction to Genprex and its mission", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/4", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "b1cbc440-01c4-465c-baef-839a0079e508", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction to Genprex and its mission", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the progress of various drug candidates through clinical phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/5", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "72f7acc8-6ffd-4be1-b677-ab995d25a4a4", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Problem statement and market sizing for cancer and diabetes", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/6", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "72f7acc8-6ffd-4be1-b677-ab995d25a4a4", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Problem statement and market sizing for cancer and diabetes", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "why_now", "function": "establish_context", "notes": "Includes a cytogenetic map showing the 600kb deletion region on chromosome 3.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/7", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-7", "loopMatches": [ { "to": 9, "from": 7, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "4368d908-7631-49a5-a2c0-c3d62cfdfbad", "evidence": "Overview of TUSC2 and Oncoprex delivery system", "position": 1, "objective": "Explain the why, what, and how of Genprex's gene therapies", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "72f7acc8-6ffd-4be1-b677-ab995d25a4a4", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Problem statement and market sizing for cancer and diabetes", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a 'brake pedal' analogy to explain biological function.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/8", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-8", "loopMatches": [ { "to": 9, "from": 7, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "4368d908-7631-49a5-a2c0-c3d62cfdfbad", "evidence": "Overview of TUSC2 and Oncoprex delivery system", "position": 1, "objective": "Explain the why, what, and how of Genprex's gene therapies", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "72f7acc8-6ffd-4be1-b677-ab995d25a4a4", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Problem statement and market sizing for cancer and diabetes", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process diagram to illustrate the mechanism of action for REQORSA gene therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/9", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-9", "loopMatches": [ { "to": 9, "from": 7, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "4368d908-7631-49a5-a2c0-c3d62cfdfbad", "evidence": "Overview of TUSC2 and Oncoprex delivery system", "position": 1, "objective": "Explain the why, what, and how of Genprex's gene therapies", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "72f7acc8-6ffd-4be1-b677-ab995d25a4a4", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Problem statement and market sizing for cancer and diabetes", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The process is presented as a sequential workflow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/10", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke visual metaphor to connect the central platform to three key value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/11", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a numbered list format to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/12", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a line chart (Seahorse XF Glycolysis Stress Test profile) and a bar chart to show metabolic impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/13", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a series of circles to present key metrics, highlighting the global market size as the central focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/14", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "ONC-001 Trial", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/15", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses fluorescence microscopy images to show the mechanism of action (selective uptake) of the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/16", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "The trial met Simon 2-stage criteria but was discontinued to prioritize a study with Tagrisso.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/17", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a 'problem-solution' framing, highlighting the limitation of existing drugs and the mechanism of the company's therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/18", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-18", "loopMatches": [ { "to": 20, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6f78c908-9d3e-4d22-b345-671df04f3614", "evidence": "Discussion of drug resistance and limited treatment options", "position": 0, "objective": "Highlight the consequences of not adopting Genprex's gene therapies", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide includes a timeline of the study and two line charts showing tumor volume over time for different treatment groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/19", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-19", "loopMatches": [ { "to": 20, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6f78c908-9d3e-4d22-b345-671df04f3614", "evidence": "Discussion of drug resistance and limited treatment options", "position": 0, "objective": "Highlight the consequences of not adopting Genprex's gene therapies", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "The slide outlines a multi-phase clinical trial structure (Phase 1, 2a, 2b) and provides specific patient counts and interim analysis milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/20", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-20", "loopMatches": [ { "to": 20, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6f78c908-9d3e-4d22-b345-671df04f3614", "evidence": "Discussion of drug resistance and limited treatment options", "position": 0, "objective": "Highlight the consequences of not adopting Genprex's gene therapies", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 20, "from": 10, "beatId": "42876aa5-a597-4386-a7a4-77eba640e28a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Solution overview and clinical trial results", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "Includes a table of enrollment/DLTs and a swimmer plot for PFS.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/21", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "solution", "function": "present_solution", "notes": "Includes a histological image showing negative TUSC2 expression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/22", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "problem_statement", "function": "frame_problem", "notes": "The table highlights a statistically significant difference (p=0.0008) in TUSC2 protein expression between SCLC and NSCLC.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/23", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "Includes Kaplan-Meier curves for Overall Survival (A) and Progression-free Survival (B).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/24", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "Kaplan-Meier survival curve showing PFS. Mentions Tecentriq as brand name for Atezolizumab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/25", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "traction", "function": "show_traction", "notes": "Includes bioluminescence imaging and quantitative bar chart with statistical significance markers (p-values).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/26", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/27", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "roadmap", "function": "plan_implementation", "notes": "Clinical trial design slide for a pharmaceutical study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/28", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "traction", "function": "show_traction", "notes": "The chart shows statistical significance (p-values) comparing treatment groups against controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/29", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "product_demo", "function": "present_solution", "notes": "The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/30", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/31", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a series of circles to present key metrics, highlighting the global expenditure figure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/32", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses an emotional image of a father and child to emphasize the human impact of the disease.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/33", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "pain_points", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/34", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "why_now", "function": "argue_timing", "notes": "Uses a timeline to establish a 'gap' in innovation, followed by three key arguments for why new therapy is needed.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/35", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a pie chart to illustrate the prevalence split between T1D and T2D.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/36", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "solution", "function": "present_solution", "notes": "Includes a scientific diagram illustrating the transition from hyperglycemia (beta-cell deficiency) to euglycemia (restored beta-cell mass) via AAV-mediated gene delivery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/37", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "traction", "function": "show_traction", "notes": "The slide compares AAV8-PM (therapeutic) against AAV8-GFP (control) and an untreated control group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/38", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/39", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a combination of a process description (left) and experimental data (line chart and bar chart) to validate the therapeutic hypothesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/40", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "fba14042-e1cc-44ad-974d-c9a2c1f21ee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "Future vision and potential impact of Genprex's gene therapies", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "traction", "function": "show_traction", "notes": "NHP = Non-Human Primate. STZ likely refers to Streptozotocin, a compound used to induce diabetes in animal models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/41", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "traction", "function": "show_traction", "notes": "ATTD likely refers to the Advanced Technologies & Treatments for Diabetes conference.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/42", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "appendix_data", "function": "analyze_data", "notes": "The data shows a significant improvement in glucose regulation post-therapy, closely tracking the normal NHP curve.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/43", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "product_demo", "function": "present_solution", "notes": "IHC stands for Immunohistochemistry. The images show DAPI (blue), Insulin (cyan), and Glucagon (red) staining.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/44", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/45", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/46", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-58c2-77ec-8b05-6d27c4bb0498", "docSlug": "35a6e53e15f172ec3a7e4b1f473eaa42", "documentTitle": "Genprex | Investor Presentation Deck | 58 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-58c2-77ec-8b05-6d27c4bb0498/47", "deckHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498", "deckAnchorHref": "/decks/019de077-58c2-77ec-8b05-6d27c4bb0498#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }